IS5273A - Lækningameðferð, sem felst í CD 154 hindrun, við lækningaprótínstálmaheilkenni - Google Patents

Lækningameðferð, sem felst í CD 154 hindrun, við lækningaprótínstálmaheilkenni

Info

Publication number
IS5273A
IS5273A IS5273A IS5273A IS5273A IS 5273 A IS5273 A IS 5273A IS 5273 A IS5273 A IS 5273A IS 5273 A IS5273 A IS 5273A IS 5273 A IS5273 A IS 5273A
Authority
IS
Iceland
Prior art keywords
graft
therapeutic
compositions
inhibition
contained
Prior art date
Application number
IS5273A
Other languages
English (en)
Icelandic (is)
Inventor
S. Kenyon Norma
Ricordi Camillo
W. Thomas David
Burkly Linda
Original Assignee
Biogen Idec Ma Inc.
University Of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Ma Inc., University Of Miami filed Critical Biogen Idec Ma Inc.
Publication of IS5273A publication Critical patent/IS5273A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Steroid Compounds (AREA)
  • External Artificial Organs (AREA)
IS5273A 1997-06-20 1999-11-26 Lækningameðferð, sem felst í CD 154 hindrun, við lækningaprótínstálmaheilkenni IS5273A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5026797P 1997-06-20 1997-06-20
US7726598P 1998-03-09 1998-03-09
PCT/US1998/012892 WO1998058669A2 (en) 1997-06-20 1998-06-19 Cd154 blockade therapy for pancreatic islet tissue transplantation

Publications (1)

Publication Number Publication Date
IS5273A true IS5273A (is) 1999-11-26

Family

ID=26728084

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5273A IS5273A (is) 1997-06-20 1999-11-26 Lækningameðferð, sem felst í CD 154 hindrun, við lækningaprótínstálmaheilkenni

Country Status (21)

Country Link
US (2) US20030072754A1 (enExample)
EP (1) EP1051191B1 (enExample)
JP (1) JP2002506446A (enExample)
KR (1) KR100634847B1 (enExample)
CN (2) CN1195546C (enExample)
AT (1) ATE339966T1 (enExample)
AU (1) AU730763B2 (enExample)
BG (1) BG64976B1 (enExample)
BR (1) BR9810620A (enExample)
CA (1) CA2294154A1 (enExample)
DE (1) DE69835965T2 (enExample)
EA (1) EA002550B1 (enExample)
EE (1) EE9900588A (enExample)
HU (1) HUP0003160A3 (enExample)
IL (1) IL133303A0 (enExample)
IS (1) IS5273A (enExample)
NO (1) NO996275L (enExample)
NZ (1) NZ502052A (enExample)
SK (1) SK180299A3 (enExample)
TR (1) TR199903142T2 (enExample)
WO (1) WO1998058669A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045958A1 (en) * 1998-03-09 1999-09-16 Biogen, Inc. Cd154 blockade therapy for modulation of immune responses to implanted devices
AU2001251612A1 (en) 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
AU2001275186A1 (en) * 2000-06-02 2001-12-17 Nicole Kirchhof Immunotherapeutic method to prevent islet cell rejection
IL152316A0 (en) * 2000-06-09 2003-05-29 Bristol Myers Squibb Co Pharmaceutical compositions and kits for treating transplant rejection
JP4667383B2 (ja) * 2003-06-13 2011-04-13 バイオジェン・アイデック・エムエイ・インコーポレイテッド アグリコシル抗ｃｄ１５４（ｃｄ４０リガンド）抗体およびその使用
EA014226B1 (ru) 2004-07-26 2010-10-29 Байоджен Айдек Ма Инк. Антитела к cd154, их фрагменты и способы применения антител и фрагментов
JP2008520235A (ja) * 2004-11-22 2008-06-19 ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド インスリンを産生可能な拡大され、かつ再分化した成体島β細胞の集団およびその作製方法
WO2007047539A2 (en) * 2005-10-14 2007-04-26 Medtronic, Inc. Localized delivery to the lymphatic system
US8636995B2 (en) 2006-08-31 2014-01-28 Cardiac Pacemakers, Inc. Methods and devices to regulate stem cell homing
US8372399B2 (en) 2006-08-31 2013-02-12 Cardiac Pacemakers, Inc. Bispecific antibodies and agents to enhance stem cell homing
US8911739B2 (en) 2009-02-10 2014-12-16 Trustees Of Columbia University In The City Of New York Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide
US9527912B2 (en) 2010-05-17 2016-12-27 The Board Of Trustees Of The Leland Stanford Junior University Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
US10147463B2 (en) 2014-12-10 2018-12-04 Nxp Usa, Inc. Video processing unit and method of buffering a source video stream
US9512229B2 (en) * 2015-03-03 2016-12-06 Kymab Limited Synergistic combinations of OX40L antibodies for the treatment of GVHD
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
US10986309B2 (en) 2015-06-30 2021-04-20 Nxp Usa, Inc. Video buffering and frame rate doubling device and method
BR112018076260A2 (pt) 2016-06-20 2019-03-26 Kymab Limited anticorpo ou fragmento do mesmo que se liga especificamente a hpd-l1, anticorpo biespecífico ou proteína de fusão, uso de um anticorpo ou fragmento, método, composição farmacêutica, método de modulação, método de inibição, método de tratamento, ácido nucleico, vetor, hospedeiro e imunocitocina
US11779604B2 (en) 2016-11-03 2023-10-10 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses and methods
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5474771A (en) * 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
US5683693A (en) * 1994-04-25 1997-11-04 Trustees Of Dartmouth College Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
JP4751493B2 (ja) * 1996-03-20 2011-08-17 ブリストル−マイヤーズ スクイッブ カンパニー Ｇｐ３９／ｃｄ４０およびｃｔｌａ４／ｃｄ２８／ｂ７経路のブロックによって免疫反応を阻止する方法およびそれに使用する組成物

Also Published As

Publication number Publication date
BR9810620A (pt) 2000-10-03
HK1033548A1 (en) 2001-09-07
EA200000058A1 (ru) 2000-08-28
BG104091A (en) 2000-10-31
EP1051191B1 (en) 2006-09-20
CN1261286A (zh) 2000-07-26
EP1051191A2 (en) 2000-11-15
WO1998058669A3 (en) 1999-04-29
CN1651919A (zh) 2005-08-10
TR199903142T2 (xx) 2000-09-21
EA002550B1 (ru) 2002-06-27
SK180299A3 (en) 2000-06-12
HUP0003160A3 (en) 2002-09-30
NO996275D0 (no) 1999-12-17
JP2002506446A (ja) 2002-02-26
WO1998058669A2 (en) 1998-12-30
US20030072754A1 (en) 2003-04-17
CA2294154A1 (en) 1998-12-30
ATE339966T1 (de) 2006-10-15
KR100634847B1 (ko) 2006-10-17
NO996275L (no) 2000-02-21
CN1195546C (zh) 2005-04-06
IL133303A0 (en) 2001-04-30
EE9900588A (et) 2000-08-15
KR20010013965A (ko) 2001-02-26
US20070292440A1 (en) 2007-12-20
AU7983098A (en) 1999-01-04
DE69835965D1 (de) 2006-11-02
NZ502052A (en) 2001-01-26
BG64976B1 (bg) 2006-11-30
AU730763B2 (en) 2001-03-15
HUP0003160A2 (hu) 2001-01-29
DE69835965T2 (de) 2007-06-14

Similar Documents

Publication Publication Date Title
IS5273A (is) Lækningameðferð, sem felst í CD 154 hindrun, við lækningaprótínstálmaheilkenni
AP2000001929A0 (en) Substituted indolealkanoic acids.
AU6285290A (en) Anticoagulant protein
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
ZA953537B (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
IL158384A0 (en) Treatment or prophylaxis of insulin producing cell graft rejection
AU2158797A (en) Benzopyran derivatives having leukotriene-antagonistic action
GB9126725D0 (en) Process
AP2001002377A0 (en) Substituted phenoxyacetic acids.
ATE169225T1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
ZA905422B (en) Substituted 2-imidazolines and preparation and use thereof
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
HU9202026D0 (en) Method and medical preparative for treatment of thrombocytopenie
EP1754490A3 (en) CD 154 blockage therapy for pancreatic islet tissue transplantation in primates
MXPA03010921A (es) Uso de acetil l-carnitina en asociacion con biotina para tratamiento der pacientes con diabetes mellitus resistente a insulina tipo 2.
IT1242475B (it) Agente colinergico, in particolare glicil-p-ammino-piridina-anilide- monoacetato, per il trattamento degli stati di demenza senile.
SE9003181D0 (sv) Use of heparin fraction
DE69231583D1 (de) Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
BE900089A (fr) Utilisation de mini-somatostatines en therapeutique.
EP0886528A4 (en) USE OF COXIELLA BACTERIA TO TREAT AUTOIMMUNE DISEASES
UA38825A (uk) Спосіб лікування запальних процесів щелепно-лицевої ділянки
MY138338A (en) Substituted indolealkanoic acids
IL117734A (en) Anellated beta-carbolines their preparation and pharmaceutical compositions containing them
IT1161871B (it) Lega a base di palladio